This information is current as Autoimmune Encephalomyelitis against Acute Fatal Experimental Costimulation Protects Rhesus Monkeys Selective Blockade of CD 28-Mediated T Cell

@inproceedings{Dijkman2015ThisII,
  title={This information is current as Autoimmune Encephalomyelitis against Acute Fatal Experimental Costimulation Protects Rhesus Monkeys Selective Blockade of CD 28-Mediated T Cell},
  author={Karin Dijkman and Noun Bashir and Jan Bauer and Caroline Mary and Nicolas Poirier and Paul Baker and Linda Scobie and Bert A.’t Hart and Bernard Vanhove},
  year={2015}
}

Figures, Tables, and Topics from this paper.

References

Publications referenced by this paper.
SHOWING 1-10 OF 49 REFERENCES

Preclinical efficacy and immunological safety of FR104, an antagonist anti-CD28 monovalent Fab' antibody.

  • American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
  • 2012
VIEW 9 EXCERPTS
HIGHLY INFLUENTIAL

Antagonizing the a4b1 integrin, but not a4b7, inhibits leukocytic infiltration of the central nervous system in rhesus monkey experimental autoimmune encephalomyelitis

K. G. Haanstra, S. O. Hofman, +7 authors E. R. Fedyk
  • J. Immunol
  • 2013
VIEW 10 EXCERPTS
HIGHLY INFLUENTIAL

A critical role for B7/CD28 costimulation in experimental autoimmune encephalomyelitis: a comparative study using costimulatory molecule-deficient mice and monoclonal antibody blockade

A. M. Girvin, M. C. Dal Canto, +4 authors S. D. Miller
  • J. Immunol
  • 2000
VIEW 3 EXCERPTS
HIGHLY INFLUENTIAL

Similar Papers

Loading similar papers…